CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 3
- ScaleLevered free cash flow is $69.03M, above the global median of $16.24M
- FinancialsAltman Z-Score 1.55: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
19.50BTRY406.31M · vs all stocks (USD)
Revenue (TTM)
12.72BTRY264.99M · vs all stocks (USD)
Profit Margin
14.96%Beta
-0.1320xvs all stocks
52-Week Change
36.66%vs all stocks
Market Capitalization
19.50BTRY406.31M · vs all stocks (USD)
Enterprise Value
42.01BTRY875.33M · vs all stocks (USD)
Forward P/E
3.73xPrice to Sales (TTM)
1.51xPrice to Book (MRQ)
0.3859xEnterprise to Revenue
3.30xEnterprise to EBITDA
9.70xGross Margin
20.58%Profit Margin
14.96%Operating Margin
13.93%Return on Assets (TTM)
1.18%Return on Equity (TTM)
4.65%Revenue (TTM)
12.72BTRY264.99M · vs all stocks (USD)
Revenue per Share (TTM)
18.20TRYUpdated Aug 21, 2026Quarterly Revenue Growth
23.70%Gross Profit (TTM)
2.16BTRY45.01M · vs all stocks (USD)
EBITDA (TTM)
8.26BTRY172.07M · vs all stocks (USD)
Net Income (TTM)
1.90BTRY39.64M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
7.48%Operating Cash Flow (TTM)
6.01BTRY125.24M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.31BTRY69.03M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
12.92BTRYFY2025 · Dec 31, 2025Cost of Goods Sold
10.11BTRYFY2025 · Dec 31, 2025Gross Profit
2.81BTRYFY2025 · Dec 31, 2025Operating Income
2.21BTRY46.05M · vs all stocks (USD)
Pre-tax Income
-1.74BTRYFY2025 · Dec 31, 2025Income Tax Expense
1.07BTRYFY2025 · Dec 31, 2025Net Income
-2.80BTRYFY2025 · Dec 31, 2025EBIT
1.12BTRYFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.40BTRYFY2025 · Dec 31, 2025Selling, General & Administrative
360.18MTRYFY2025 · Dec 31, 2025Other Operating Expenses
31.66MTRYFY2025 · Dec 31, 2025Non-operating Interest Income
274.59MTRYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.86BTRYFY2025 · Dec 31, 2025Net Income from Continuing Operations
-2.80BTRYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025Operating Cash Flow
-4.74BTRYFY2025 · Dec 31, 2025Free Cash Flow
-5.03BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.31BTRYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-2.80BTRYFY2025 · Dec 31, 2025Other Non-cash Items
-5.49BTRYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
2.56BTRYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
986.02MTRYFY2025 · Dec 31, 2025Capital Expenditures
-284.45MTRYFY2025 · Dec 31, 2025Purchase of Investments
-24.86BTRYFY2025 · Dec 31, 2025Sale of Investments
25.73BTRYFY2025 · Dec 31, 2025Net Investing Cash Flow
581.96MTRYFY2025 · Dec 31, 2025Long-term Debt Issuance
23.28BTRYFY2025 · Dec 31, 2025Net Financing Cash Flow
23.28BTRYFY2025 · Dec 31, 2025Shares Outstanding
705.00MSharesUpdated Aug 21, 2026Float Shares
124.02MSharesUpdated Aug 21, 2026% Held by Insiders
81.56%vs all stocks
% Held by Institutions
0.99%vs all stocks
Total Cash (MRQ)
2.37BTRY49.38M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.39TRYUpdated Aug 21, 2026Total Debt (MRQ)
25.38BTRY528.90M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5157xCurrent Ratio (MRQ)
1.57xBook Value per Share (MRQ)
70.38TRYUpdated Aug 21, 2026Total Assets
68.54BTRY1.43B · vs all stocks (USD)
Total Current Assets
3.46BTRYFY2025 · Dec 31, 2025Total Liabilities
31.75BTRYFY2025 · Dec 31, 2025Total Non-current Assets
65.08BTRYFY2025 · Dec 31, 2025Total Non-current Liabilities
28.95BTRYFY2025 · Dec 31, 2025Total Current Liabilities
2.80BTRYFY2025 · Dec 31, 2025Cash
3.35MTRYFY2025 · Dec 31, 2025Cash Equivalents
1.31BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.31BTRYFY2025 · Dec 31, 2025Other Short-term Investments
50.82MTRYFY2025 · Dec 31, 2025Accounts Receivable
1.75BTRYFY2025 · Dec 31, 2025Inventory
31.54MTRYFY2025 · Dec 31, 2025Accounts Payable
223.20MTRYFY2025 · Dec 31, 2025Short-term Debt
2.22BTRYFY2025 · Dec 31, 2025Other Current Liabilities
113.01MTRYFY2025 · Dec 31, 2025Long-term Debt
21.03BTRYFY2025 · Dec 31, 2025Common Stock (Book)
705.00MTRYFY2025 · Dec 31, 2025Retained Earnings
45.51BTRYFY2025 · Dec 31, 2025Total Shareholders' Equity
36.79BTRY766.64M · vs all stocks (USD)
Treasury Stock
221.46MTRYFY2025 · Dec 31, 202552-Week Low
16.99TRYUpdated Aug 21, 202652-Week High
33.20TRYUpdated Aug 21, 202652-Week Change
36.66%vs all stocks
Beta
-0.1320xvs all stocks
50-Day MA
25.37TRYUpdated Aug 21, 2026200-Day MA
24.73TRYUpdated Aug 21, 2026Avg 10-Day Volume
6.54MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.68MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-3.88TRYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.55: grey zoneSignificant
Altman Z-Score: 1.55
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Levered free cash flow is $69.03M, above the global median of $16.24MNotable
Levered free cash flow (USD): 69,028,797.222Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Yabo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hysum Flexibles Global Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Innover Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Avit Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Protec Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Pace Digitek Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shaanxi Meibang Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Yest Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shenzhen Changfang Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Terasaki Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking